51. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
- Author
-
Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, and Orr HT
- Subjects
- Animals, Ataxia chemically induced, Ataxin-1, Ataxins, COS Cells, Cell Nucleus metabolism, Cytoplasm metabolism, Mice, Mice, Transgenic, Nerve Tissue Proteins genetics, Nerve Tissue Proteins physiology, Neurodegenerative Diseases etiology, Nuclear Localization Signals genetics, Nuclear Localization Signals physiology, Nuclear Proteins genetics, Nuclear Proteins physiology, Peptides, Purkinje Cells metabolism, Ataxia metabolism, Nerve Tissue Proteins metabolism, Nuclear Proteins metabolism
- Abstract
Transgenic mice carrying the spinocerebellar ataxia type 1 (SCA1) gene, a polyglutamine neurodegenerative disorder, develop ataxia with ataxin-1 localized to aggregates within cerebellar Purkinje cells nuclei. To examine the importance of nuclear localization and aggregation in pathogenesis, mice expressing ataxin-1[82] with a mutated NLS were established. These mice did not develop disease, demonstrating that nuclear localization is critical for pathogenesis. In a second series of transgenic mice, ataxin-1[77] containing a deletion within the self-association region was expressed within Purkinje cells nuclei. These mice developed ataxia and Purkinje cell pathology similar to the original SCA1 mice. However, no evidence of nuclear ataxin-1 aggregates was found. Thus, although nuclear localization of ataxin-1 is necessary, nuclear aggregation of ataxin-1 is not required to initiate pathogenesis in transgenic mice.
- Published
- 1998
- Full Text
- View/download PDF